BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 11668621)

  • 1. Eleven novel JAK3 mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain.
    Mella P; Schumacher RF; Cranston T; de Saint Basile G; Savoldi G; Notarangelo LD
    Hum Mutat; 2001 Oct; 18(4):355-6. PubMed ID: 11668621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
    Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
    Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected and variable phenotypes in a family with JAK3 deficiency.
    Frucht DM; Gadina M; Jagadeesh GJ; Aksentijevich I; Takada K; Bleesing JJ; Nelson J; Muul LM; Perham G; Morgan G; Gerritsen EJ; Schumacher RF; Mella P; Veys PA; Fleisher TA; Kaminski ER; Notarangelo LD; O'Shea JJ; Candotti F
    Genes Immun; 2001 Dec; 2(8):422-32. PubMed ID: 11781709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
    Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
    Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency.
    Notarangelo LD; Mella P; Jones A; de Saint Basile G; Savoldi G; Cranston T; Vihinen M; Schumacher RF
    Hum Mutat; 2001 Oct; 18(4):255-63. PubMed ID: 11668610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid protein-based assays for the diagnosis of T-B+ severe combined immunodeficiency.
    Gilmour KC; Cranston T; Loughlin S; Gwyther J; Lester T; Espanol T; Hernandez M; Savoldi G; Davies EG; Abinun M; Kinnon C; Jones A; Gaspar HB
    Br J Haematol; 2001 Mar; 112(3):671-6. PubMed ID: 11260071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: evidence for interactions between the kinase and pseudokinase domains.
    Chen M; Cheng A; Candotti F; Zhou YJ; Hymel A; Fasth A; Notarangelo LD; O'Shea JJ
    Mol Cell Biol; 2000 Feb; 20(3):947-56. PubMed ID: 10629052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency.
    Vihinen M; Villa A; Mella P; Schumacher RF; Savoldi G; O'Shea JJ; Candotti F; Notarangelo LD
    Clin Immunol; 2000 Aug; 96(2):108-18. PubMed ID: 10900158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Janus kinase 3 (JAK3) deficiency: clinical, immunologic, and molecular analyses of 10 patients and outcomes of stem cell transplantation.
    Roberts JL; Lengi A; Brown SM; Chen M; Zhou YJ; O'Shea JJ; Buckley RH
    Blood; 2004 Mar; 103(6):2009-18. PubMed ID: 14615376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
    Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
    J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deep intronic mis-splicing mutation in JAK3 gene underlies T-B+NK- severe combined immunodeficiency phenotype.
    Stepensky P; Keller B; Shamriz O; NaserEddin A; Rumman N; Weintraub M; Warnatz K; Elpeleg O; Barak Y
    Clin Immunol; 2016 Feb; 163():91-5. PubMed ID: 26769277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID).
    Macchi P; Villa A; Giliani S; Sacco MG; Frattini A; Porta F; Ugazio AG; Johnston JA; Candotti F; O'Shea JJ
    Nature; 1995 Sep; 377(6544):65-8. PubMed ID: 7659163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and functional basis for JAK3-deficient severe combined immunodeficiency.
    Candotti F; Oakes SA; Johnston JA; Giliani S; Schumacher RF; Mella P; Fiorini M; Ugazio AG; Badolato R; Notarangelo LD; Bozzi F; Macchi P; Strina D; Vezzoni P; Blaese RM; O'Shea JJ; Villa A
    Blood; 1997 Nov; 90(10):3996-4003. PubMed ID: 9354668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
    Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
    Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID.
    Russell SM; Johnston JA; Noguchi M; Kawamura M; Bacon CM; Friedmann M; Berg M; McVicar DW; Witthuhn BA; Silvennoinen O
    Science; 1994 Nov; 266(5187):1042-5. PubMed ID: 7973658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of autologous, oligoclonal, poorly functioning T lymphocytes in a patient with autosomal recessive severe combined immunodeficiency caused by defects of the Jak3 tyrosine kinase.
    Brugnoni D; Notarangelo LD; Sottini A; AirĂ² P; Pennacchio M; Mazzolari E; Signorini S; Candotti F; Villa A; Mella P; Vezzoni P; Cattaneo R; Ugazio AG; Imberti L
    Blood; 1998 Feb; 91(3):949-55. PubMed ID: 9446656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic structure and promoter region of the murine Janus-family tyrosine kinase, Jak3.
    Gurniak CB; Thomis DC; Berg LJ
    DNA Cell Biol; 1997 Jan; 16(1):85-94. PubMed ID: 9022047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complete genomic organization of the human JAK3 gene and mutation analysis in severe combined immunodeficiency by single-strand conformation polymorphism.
    Schumacher RF; Mella P; Badolato R; Fiorini M; Savoldi G; Giliani S; Villa A; Candotti F; Tampalini A; O'Shea JJ; Notarangelo LD
    Hum Genet; 2000 Jan; 106(1):73-9. PubMed ID: 10982185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
    Roifman CM; Zhang J; Chitayat D; Sharfe N
    Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.